Table 2.
Characteristics of HAND and HIV-1-negative individuals, CSF.
| CSF ID | Gender (M/F) | Age (year) | Race | NeuroAIDS status | CSF viral load (log10/mL) | cART |
|---|---|---|---|---|---|---|
| HAND | ||||||
| NNTC005 | F | 38 | NW | ANI | 4.9 | missing |
| NNTC026 | M | 44 | W | ANI | missing | ABC + APV + EFV |
| NNTC012 | M | 42 | NW | ANI | 3.9 | missing |
| NNTC037 | M | 54 | W | ANI | 4.9 | ART- |
| NNTC010 | M | 62 | W | MND | missing | 3TC + KTA + RTV + TFV |
| NNTC068 | M | 60 | W | MND | missing | missing |
| NNTC058 | M | 47 | W | HAD | 1.7 | 3TC + ABC + APV |
| NNTC126 | M | 61 | W | HAD | 1.7 | ATV + EPZ + RTV |
| HIV-1-negative | ||||||
| T44 | M | 54 | ||||
| T45 | F | 57 | ||||
| T51 | F | 69 | ||||
| T52 | F | 24 | ||||
| T53 | F | 74 | ||||
| T54 | F | 76 | ||||
| T55 | F | 24 | ||||
| T56 | M | 91 | ||||
| T57 | F | 46 |
Note: M, male; F, female; W, white; NW, non-white; ANI, asymptomatic neurocognitive impairment; MND, mild neurocognitive disorder; HAD, HIV-1-associated dementia; ABC, abacavir; APV, amprenavir; EFV, efavirenz; 3TC, lamivudine; KTA, lopinavir/ritonavir; RTV, ritonavir; TFV, tenofivir; ATV, atazanavir; EPZ, ABC + lamivudine.